Invivo Therapeutics Holdings Corp (OTCBB:NVIV) Appointment of New CFO

Repost This

Las Vegas, NV -- (SBWIRE) -- 09/24/2013 -- Invivo Therapeutics Holdings Corp (OTCBB:NVIV) announced that Gregory D. Perry has been appointed as interim CFO and commenced on 23rd September, 2013.

Mr. Perry was the Executive Vice President and CFO of Immunogen, Inc. Mr. Perry served as CFO of Elixir Pharmaceuticals, Inc. from 2007 to 2009 before he joined Immunogen Inc. He was also the CFO of Domantis Ltd., which was acquired by GlaxoSmithKline in 2006. Mr. Perry was Senior Vice President and CFO of Transkaryotic Therapies, Inc. previously until its acquisition by Shire plc in 2005. Mr. Perry is currently a member of the Board of Directors of Advanced Cell Technology, Inc.

The interim CEO of Invivo Therapeutics Holdings Corp, Mike Astrue stated that the company is excited to bring on board a CFO with the integrity, talent and experience of Greg Perry. He added that his breadth of experience can add value to InVivo in a variety of ways.

To find out what ChartPoppers projects for Invivo Therapeutics Holdings Corp. for both short term and long term please click here: NVIV

ChartPoppers Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit ChartPoppers right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly ChartPoppers is the hottest thing in Hot Stocks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at Release of Liability: Through use of this website viewing or using you agree to hold, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical., nor any of its affiliates are not registered investment advisors or broker dealers.